Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Identification of AGI1-A, a variant of Acinetobacter genomic island 1 (AGI1), in a French clinical isolate belonging to the Enterobacter cloacae complex.

Siebor E, de Curraize C, Neuwirth C.

J Antimicrob Chemother. 2019 Feb 1;74(2):311-314. doi: 10.1093/jac/dky442.

PMID:
30412264
2.

Genomic context of resistance genes within a French clinical MDR Proteus mirabilis: identification of the novel genomic resistance island GIPmi1.

Siebor E, de Curraize C, Neuwirth C.

J Antimicrob Chemother. 2018 Jul 1;73(7):1808-1811. doi: 10.1093/jac/dky126.

PMID:
29669108
3.

Two new Salmonella genomic islands 1 from Proteus mirabilis and description of blaCTX-M-15 on a variant (SGI1-K7).

de Curraize C, Neuwirth C, Bador J, Chapuis A, Amoureux L, Siebor E.

J Antimicrob Chemother. 2018 Jul 1;73(7):1804-1807. doi: 10.1093/jac/dky108.

PMID:
29659873
4.

"Does the Salmonella Genomic Island 1 (SGI1) confer invasiveness properties to human isolates?"

de Curraize C, Amoureux L, Bador J, Chapuis A, Siebor E, Clément C, Sauge J, Aho-Glélé LS, Neuwirth C.

BMC Infect Dis. 2017 Dec 1;17(1):741. doi: 10.1186/s12879-017-2847-1.

5.

Nosocomial Infections with IMP-19-Producing Pseudomonas aeruginosa Linked to Contaminated Sinks, France.

Amoureux L, Riedweg K, Chapuis A, Bador J, Siebor E, Péchinot A, Chrétien ML, de Curraize C, Neuwirth C.

Emerg Infect Dis. 2017 Feb;23(2):304-307. doi: 10.3201/eid2302.160649.

6.

Occurence of ArmA and RmtB Aminoglycoside Resistance 16S rRNA Methylases in Extended-Spectrum β-Lactamases Producing Escherichia coli in Algerian Hospitals.

Ayad A, Drissi M, de Curraize C, Dupont C, Hartmann A, Solanas S, Siebor E, Amoureux L, Neuwirth C.

Front Microbiol. 2016 Sep 12;7:1409. doi: 10.3389/fmicb.2016.01409. eCollection 2016.

7.

Outbreak of Extended-Spectrum Beta-Lactamase Producing Enterobacter cloacae with High MICs of Quaternary Ammonium Compounds in a Hematology Ward Associated with Contaminated Sinks.

Chapuis A, Amoureux L, Bador J, Gavalas A, Siebor E, Chrétien ML, Caillot D, Janin M, de Curraize C, Neuwirth C.

Front Microbiol. 2016 Jul 12;7:1070. doi: 10.3389/fmicb.2016.01070. eCollection 2016.

8.

Mobilization of the Salmonella genomic island SGI1 and the Proteus genomic island PGI1 by the A/C2 plasmid carrying blaTEM-24 harboured by various clinical species of Enterobacteriaceae.

Siebor E, de Curraize C, Amoureux L, Neuwirth C.

J Antimicrob Chemother. 2016 Aug;71(8):2167-70. doi: 10.1093/jac/dkw151. Epub 2016 May 5.

PMID:
27150396
9.

Survey of multidrug resistance integrative mobilizable elements SGI1 and PGI1 in Proteus mirabilis in humans and dogs in France, 2010-13.

Schultz E, Haenni M, Mereghetti L, Siebor E, Neuwirth C, Madec JY, Cloeckaert A, Doublet B.

J Antimicrob Chemother. 2015 Sep;70(9):2543-6. doi: 10.1093/jac/dkv154. Epub 2015 Jun 11.

PMID:
26066582
10.

Proteus genomic island 1 (PGI1), a new resistance genomic island from two Proteus mirabilis French clinical isolates.

Siebor E, Neuwirth C.

J Antimicrob Chemother. 2014 Dec;69(12):3216-20. doi: 10.1093/jac/dku314. Epub 2014 Aug 11.

PMID:
25114166
11.

Emergence of Salmonella genomic island 1 (SGI1) among Proteus mirabilis clinical isolates in Dijon, France.

Siebor E, Neuwirth C.

J Antimicrob Chemother. 2013 Aug;68(8):1750-6. doi: 10.1093/jac/dkt100. Epub 2013 Apr 10.

PMID:
23580563
12.

Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data.

Amoureux L, Bador J, Siebor E, Taillefumier N, Fanton A, Neuwirth C.

J Cyst Fibros. 2013 Mar;12(2):170-6. doi: 10.1016/j.jcf.2012.08.005. Epub 2012 Sep 1.

13.
14.

First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM.

Bador J, Amoureux L, Duez JM, Drabowicz A, Siebor E, Llanes C, Neuwirth C.

Antimicrob Agents Chemother. 2011 Oct;55(10):4912-4. doi: 10.1128/AAC.00341-11. Epub 2011 Aug 1.

15.

In vitro synergistic activity of combined piperacillin and tobramycin against clinical strains of Achromobacter xylosoxidans.

Duez JM, Hadjait-Savioz M, Siebor E, Astruc K, Bador J, Péchinot A, Sixt N, Huet F, Neuwirth C.

J Chemother. 2010 Apr;22(2):139-41. No abstract available.

PMID:
20435577
16.

In vitro combinations of five intravenous antibiotics with dalfopristin-quinupristin against Staphylococcus aureus in a 3-dimensional model.

Duez JM, Adochitei A, Péchinot A, Siebor E, Sixt N, Neuwirth C.

J Chemother. 2008 Dec;20(6):684-9.

PMID:
19129064
17.

First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France.

Neuwirth C, Siebor E, Robin F, Bonnet R.

Antimicrob Agents Chemother. 2007 Dec;51(12):4486-8. Epub 2007 Oct 15.

18.

Presumed pseudobacteremia outbreak resulting from contamination of proportional disinfectant dispenser.

Siebor E, Llanes C, Lafon I, Ogier-Desserrey A, Duez JM, Pechinot A, Caillot D, Grandjean M, Sixt N, Neuwirth C.

Eur J Clin Microbiol Infect Dis. 2007 Mar;26(3):195-8.

PMID:
17393202
19.

VEB-1 in Achromobacter xylosoxidans from cystic fibrosis patient, France.

Neuwirth C, Freby C, Ogier-Desserrey A, Perez-Martin S, Houzel A, Péchinot A, Duez JM, Huet F, Siebor E.

Emerg Infect Dis. 2006 Nov;12(11):1737-9. No abstract available.

20.

One new LEN enzyme and two new OKP enzymes in Klebsiella pneumoniae clinical isolates and proposed nomenclature for chromosomal beta-lactamases of this species.

Siebor E, Péchinot A, Duez JM, Neuwirth C.

Antimicrob Agents Chemother. 2005 Jul;49(7):3097-8. No abstract available.

21.

Survey of Enterobacteriaceae producing extended-spectrum beta-lactamases in a Slovak hospital: dominance of SHV-2a and characterization of TEM-132.

Zarnayová M, Siebor E, Péchinot A, Duez JM, Bujdáková H, Labia R, Neuwirth C.

Antimicrob Agents Chemother. 2005 Jul;49(7):3066-9.

22.

Outer membrane protein profiles of clonally related Klebsiella pneumoniae isolates that differ in cefoxitin resistance.

Skopková-Zarnayová M, Siebor E, Rovná D, Bujdáková H, Neuwirth C.

FEMS Microbiol Lett. 2005 Feb 1;243(1):197-203.

23.

Molecular epidemiology of Enterobacteriaceae producing extended-spectrum beta-lactamase in a French university-affiliated hospital.

Bertrand X, Hocquet D, Boisson K, Siebor E, Plésiat P, Talon D.

Int J Antimicrob Agents. 2003 Aug;22(2):128-33.

PMID:
12927952
24.

First isolation of CTX-M15-producing Escherichia coli from two French patients.

Neuwirth C, Siebor E, Pruneaux M, Zarnayova M, Simonin C, Kisterman JP, Labia R.

J Antimicrob Chemother. 2003 Feb;51(2):471-3. No abstract available.

PMID:
12562730
25.

TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.

Neuwirth C, Madec S, Siebor E, Pechinot A, Duez JM, Pruneaux M, Fouchereau-Peron M, Kazmierczak A, Labia R.

Antimicrob Agents Chemother. 2001 Dec;45(12):3591-4.

26.

Evidence of in vivo transfer of a plasmid encoding the extended-spectrum beta-lactamase TEM-24 and other resistance factors among different members of the family Enterobacteriaceae.

Neuwirth C, Siebor E, Pechinot A, Duez JM, Pruneaux M, Garel F, Kazmierczak A, Labia R.

J Clin Microbiol. 2001 May;39(5):1985-8.

27.

Characterization of TEM-56, a novel beta-lactamase produced by a Klebsiella pneumoniae clinical isolate.

Neuwirth C, Labia R, Siebor E, Pechinot A, Madec S, Chaibi EB, Kazmierczak A.

Antimicrob Agents Chemother. 2000 Feb;44(2):453-5.

30.

Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins.

Neuwirth C, Siébor E, Duez JM, Péchinot A, Kazmierczak A.

J Antimicrob Chemother. 1995 Aug;36(2):335-42.

PMID:
8522463
31.

[In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin].

Duez JM, Siebor E, Pechinot A, Cordin X, Chamard-Neuwirth C, Kazmierczak A.

Pathol Biol (Paris). 1995 Mar;43(3):208-14. French.

PMID:
7675548
32.

[In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].

Kazmierczak A, Siebor E, Acar JF, Denis F, Drugeon H, Fleurette J, Sirot J, Soussy CJ, Thabaut A.

Pathol Biol (Paris). 1991 May;39(5):384-90. French.

PMID:
1909015
33.

[Diffusion of imipenem in synovial fluid].

Péchinot A, Arnould H, Baulot E, Péchinot M, Siebor E, Kazmierczak A.

Pathol Biol (Paris). 1991 May;39(5):503-6. French.

PMID:
1881683
34.

[Uptake of ofloxacin by Escherichia coli].

Péchinot A, Duez JM, Siebor E, Mattioni D, Kazmierczak A.

Pathol Biol (Paris). 1991 May;39(5):410-9. French.

PMID:
1881671
35.

[In vitro synergistic activity of piperacillin-tazobactam combination against beta-lactam antibiotics resistant strains of Enterobacteriaceae].

Duex JM, Cordin X, Péchinot A, Siebor E, Kazmierczak A.

Pathol Biol (Paris). 1991 May;39(5):374-8. French.

PMID:
1652728
36.

[Comparative study of the antibacterial activity of cefpodoxime against enterobacteria producing beta lactamases].

Siebor E, Cordin X, Delpech N, Duez JM, Kazmierczak A.

Pathol Biol (Paris). 1990 May;38(5):331-5. French.

PMID:
2367149
37.

Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.

Kazmierczak A, Cordin X, Duez JM, Siebor E, Pechinot A, Sirot J.

J Int Med Res. 1990;18 Suppl 4:67D-77D.

PMID:
2282971
38.

Sulbactam: secondary mechanisms of action.

Kazmierczak A, Pechinot A, Siebor E, Cordin X, Labia R.

Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4 Suppl):139S-146S.

PMID:
2591173
39.

[Bactericidal activity of daptomycin and vancomycin alone or in combination with tobramycin, netilmicin or ampicillin against enterococcus].

Duez JM, Péchinot A, Siébor E, Cordin X, Kazmierczak A.

Pathol Biol (Paris). 1989 Apr;37(4):263-8. French.

PMID:
2543946
40.

[Bactericidal activity of amoxicillin and cefaclor in an "in vitro" kinetic model (author's transl)].

Pothier P, Kazmierczak A, Siebor E, Gaillard MC, Pechinot A.

Ann Microbiol (Paris). 1981 May-Jun;132(3):293-306. French.

PMID:
7027869
41.

[Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin].

Kazmierczak A, Gailliard MC, Pothier P, Siebor E, Portier H.

Nouv Presse Med. 1979 Oct 31;8(42):3399-402. French. No abstract available.

PMID:
537884
42.

[Activity of cefamandole against enterobacteria resistant to cephalosporins (author's transl)].

Kazmierczak A, Gailliard MC, Portier H, Siebor E, Labia R.

Nouv Presse Med. 1979 Oct 15;8(39):3157-60. French.

PMID:
261332

Supplemental Content

Loading ...
Support Center